Obstetrics

Dr. Marra Francis Joins Genece Health as Chief Medical Officer

Retrieved on: 
Wednesday, April 3, 2024
Health, Obstetrics, Faculty, Gynaecology, Physician, FACOG, DEL, Memorial Hermann–Texas Medical Center, Lung, Breast, University, MD, Biology, Ovary, Cancer, Liquid biopsy, GeneDx, Occidental College

DEL MAR, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer detection for lung, breast, ovarian and other cancers, today announced that Marra Francis, MD, FACOG, has joined the company as its chief medical officer.

Key Points: 
  • DEL MAR, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer detection for lung, breast, ovarian and other cancers, today announced that Marra Francis, MD, FACOG, has joined the company as its chief medical officer.
  • Dr. Francis’ past experience also includes serving as head of medical affairs for women's health of Sema4 (now GeneDx); as executive medical director of EverlyWell; and as chief medical officer of Aspira Women's Health.
  • Dr. Francis holds a medical degree from the University of Connecticut Health Center and a bachelor of arts degree in biology from Occidental College.
  • “We are delighted to have Marra join our team at a very exciting time for Genece,” said Greg Gosch, CEO of Genece Heath.

Association of Black Cardiologists' "We Are The Faces" Campaign Unveils New Videos for Black Maternal Health Week

Retrieved on: 
Saturday, April 6, 2024
Mother, Disease, Health, ABC, Cardiovascular disease, Cardiology, Patient, Mortality, Pregnancy, Spouse, Collection, Obstetrics

WASHINGTON, April 6, 2024 /PRNewswire/ -- In celebration of Black Maternal Health Week (April 11-17, 2024) and April's Minority Health Month, the Association of Black Cardiologists (ABC) is proud to unveil a new slate of videos as part of its third year of the "We Are The Faces of Black Maternal Health" awareness and advocacy campaign.

Key Points: 
  • WASHINGTON, April 6, 2024 /PRNewswire/ -- In celebration of Black Maternal Health Week (April 11-17, 2024) and April's Minority Health Month, the Association of Black Cardiologists (ABC) is proud to unveil a new slate of videos as part of its third year of the "We Are The Faces of Black Maternal Health" awareness and advocacy campaign.
  • This series amplifies the intergenerational impact of the Black maternal health crisis and underscores the critical role of healthcare professionals in addressing racial disparities in maternal health outcomes.
  • ABC members are uniquely positioned to address the maternal health crisis, given the intersection of maternal health and cardiovascular well-being.
  • Together, we can effect tangible change and rewrite the narrative on Black maternal health.

TGH Women's Institute Receives Highest Honor from National Accrediting Body

Retrieved on: 
Friday, April 5, 2024
Hospital, Mother, Midwifery, Tampa General Hospital, Obstetrics, Certification, Chair, Gynaecology, Joint Commission, Health, TGH, Patient, DNP, Accreditation, Infant, Pregnancy, Woman, MPH, Safety, Nursing care plan, Physician, Nursing

TAMPA, Fla., April 5, 2024 /PRNewswire/ -- The Women's Institute at Tampa General Hospital (TGH) announced that it has received the highest national designation (Level IV) in maternal care from The Joint Commission — the gold standard in accreditation — underscoring its commitment to excellence in care for mothers and babies.

Key Points: 
  • The Joint Commission, a nonprofit organization dedicated to empowering health care organizations in providing the highest level of safety and quality, verified the TGH Women's Institute as a Level IV Maternal Care hospital.
  • Founded in 1951, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care.
  • The TGH Women's Institute provides a full range of women's health services, from routine obstetrics and gynecology to more complex maternal-fetal medicine and neonatal care.
  • The Institute is one of only 11 health care facilities in Florida and the only one in Hillsborough County to receive this distinction.

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

Retrieved on: 
Thursday, March 21, 2024
ART, Obstetrics, Fireside, Gynaecology, Infertility, Case Western Reserve University, IVF, Climate, University, Woman, Reproductive biology, FDA

Those interested in attending the event, which will be held virtually TODAY, March 21, 2024 at 1PM ET, may register here.

Key Points: 
  • Those interested in attending the event, which will be held virtually TODAY, March 21, 2024 at 1PM ET, may register here.
  • will focus on the current treatment options in the infertility services market, including Femasys’ FDA-authorized FemaSeed device for intratubal insemination.
  • Ms. Lee-Sepsick is the founder of Femasys and has nearly three decades of experience as a senior executive in the medical technology industry.
  • She is the lead inventor of the technologies at Femasys and remains committed to advancing much needed technology in women’s health.

Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Center

Retrieved on: 
Wednesday, March 13, 2024
Internal medicine, Obstetrics, Ventricular septal defect, Gynaecology, Cardiology, Pediatric nursing, Education, Pulmonary hypertension, Patient, Duke University, SVP, Research, Electrophysiology, University, Pregnancy, Quality, Pediatrics, Hospital, Safety, Division, Children's National Hospital, Baylor University, Williams College

Washington, D.C., March 13, 2024 (GLOBE NEWSWIRE) -- Children's National Hospital has appointed Wayne J. Franklin, M.D., F.A.C.C., as the new senior vice president (SVP) of the Children’s National Heart Center .

Key Points: 
  • Washington, D.C., March 13, 2024 (GLOBE NEWSWIRE) -- Children's National Hospital has appointed Wayne J. Franklin, M.D., F.A.C.C., as the new senior vice president (SVP) of the Children’s National Heart Center .
  • Dr. Franklin currently serves as co-director, medical director of Quality and endowed chair in the Center for Heart Care and associate director of the Adult Congenital Heart Disease Program at Phoenix Children’s.
  • “I look forward to leading the exceptional Heart Center team at Children’s National, as we contribute to advancing pediatric cardiac care and research,” said Dr. Franklin.
  • “Together with our Heart Center leadership team, he will ensure we’re meeting the highest standards of safety, quality and innovative care for our patients and families.”
    The Children’s National Heart Center is a multidisciplinary center that provides high-quality and innovative pediatric cardiac care.

Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024

Retrieved on: 
Wednesday, March 13, 2024
ART, Obstetrics, Fireside, Gynaecology, Infertility, Case Western Reserve University, IVF, Climate, University, Woman, Reproductive biology, FDA

ATLANTA, March 13, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting the significant unmet needs for women worldwide with a broad portfolio of in-office, accessible and innovative therapeutic and diagnostic products, announces it will participate in a Fireside Chat with Jones Trading Analyst Catherine Novack to discuss the current treatment landscape for infertility treatment in women. Those interested in attending the event, which will be held virtually on March 21, 2024 at 1PM ET, may register here.

Key Points: 
  • Those interested in attending the event, which will be held virtually on March 21, 2024 at 1PM ET, may register here.
  • will focus on the current treatment options in the infertility services market, including Femasys’ FDA-authorized FemaSeed device for intratubal insemination.
  • Ms. Lee-Sepsick is the founder of Femasys and has nearly three decades of experience as a senior executive in the medical technology industry.
  • She is the lead inventor of the technologies at Femasys and remains committed to advancing much needed technology in women’s health.

Adtalem Achieves 97% First-Time Residency Attainment Rate and Growing1

Retrieved on: 
Monday, March 25, 2024
General Health, Health, Continuing, University, Education, Obstetrics, Adtalem Global Education, Gynaecology, American University, Med-Peds, ATGE, Physician, RUSM, AUC, Internal, Black, Student, Orthopedic surgery, Health equity, Nursing

These students and graduates will aid in combating the physician shortage that could exceed 120,000 by 2034.

Key Points: 
  • These students and graduates will aid in combating the physician shortage that could exceed 120,000 by 2034.
  • The success of this year's match reflects the quality of Adtalem's programs and the strong demand for its medical school graduates.
  • For comprehensive lists of residency placements, please visit the AUC and RUSM websites.
  • To learn more about Adtalem’s Match Day 2024, visit the Adtalem Newsroom .

Ivy Fertility Hires Dr. Bryn Willson and Dr. Shelun Tsai

Retrieved on: 
Thursday, March 21, 2024
Baby, Maternity, Managed Care, Other Health, Health, Women, Other Science, Research, Hospitals, Genetics, Consumer, Science, Cedars-Sinai Medical Center, Education, Weill Cornell Medicine, SDFC, Patient, Duke University, UC, University, Weill Cornell Medical Center, MD, Pacific coast, Infertility, Gynaecology, Harvard University, University of California, Davis, Santa Clara University, Golden apple, Obstetrics, Duke, Physician, Hedera

Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Bryn Willson, MD and Shelun Tsai, MD to its collaborative team of physicians.

Key Points: 
  • Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Bryn Willson, MD and Shelun Tsai, MD to its collaborative team of physicians.
  • Dr. Willson and Dr. Tsai are both board-certified in obstetrics and gynecology, and will complete their fellowships in reproductive endocrinology this spring.
  • “The entire Ivy Fertility network is committed to staying at the forefront of fertility science,” said Sandy Chuan, MD, Medical Director at San Diego Fertility Center.
  • “We are privileged that Dr. Willson and Dr. Tsai will be contributing their innovation and compassion to our network.”

Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT) Significantly Improved Overall Survival (OS) Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer

Retrieved on: 
Friday, March 15, 2024
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, FDA, Clinical Trials, MSD, OS, Chemoradiotherapy, CRT, Obstetrics, Congress, Gynaecology, CPS, Survival, Disease, Progression-free survival, Data monitoring committee, Cervical cancer, Patient, Neoplasm, Merck & Co., Overalls, Humanitas University, Bevacizumab, MRK, Cancer, ESMO, PFS, FIGO, PD-L1, Food, Pharmaceutical industry

At a pre-specified interim analysis conducted by an independent Data Monitoring Committee, KEYTRUDA in combination with concurrent CRT showed a statistically significant and clinically meaningful improvement in OS versus concurrent CRT alone.

Key Points: 
  • At a pre-specified interim analysis conducted by an independent Data Monitoring Committee, KEYTRUDA in combination with concurrent CRT showed a statistically significant and clinically meaningful improvement in OS versus concurrent CRT alone.
  • The safety profile of KEYTRUDA in this trial was consistent with that observed in previously reported studies; no new safety signals were identified.
  • Results will be presented at an upcoming medical meeting and shared with regulatory authorities worldwide.
  • As previously reported , KEYNOTE-A18 met its other primary endpoint of progression-free survival (PFS) in 2023.

BayCare Reveals Plans for New Hospital in Manatee County

Retrieved on: 
Wednesday, April 3, 2024
I-275, Health, MRI, Growth, Central Florida, Urology, Bed, Cardiology, Patient, I-75, Hospital, Mammography, Obstetrics, Physician, Neonatology, Gastroenterology

CLEARWATER, Fla., April 3, 2024 /PRNewswire/ -- BayCare Health System announced construction plans today for its newest hospital, a comprehensive acute care facility to serve the rapidly growing community of Manatee County. BayCare Hospital Manatee will be the county's first not-for-profit hospital and the only hospital north of Manatee River.

Key Points: 
  • CLEARWATER, Fla., April 3, 2024 /PRNewswire/ -- BayCare Health System announced construction plans today for its newest hospital, a comprehensive acute care facility to serve the rapidly growing community of Manatee County.
  • BayCare Hospital Manatee will be the county's first not-for-profit hospital and the only hospital north of Manatee River.
  • BayCare Hospital Manatee will be the county's first not-for-profit hospital.
  • BayCare anticipates opening the hospital, its 17th, in 2027 with 154 beds in private patient rooms.